This trial will study the performance and safety of two types of surgical wound-closure products.
- Surgical Wound
- Non-healing Surgical Wound
- Surgical Incision
- Surgical Wounds
1 Primary · 3 Secondary · Reporting Duration: 14-days post-surgery
14 days post-surgery
Incidence of wound dehiscence
Safety of Liquiband Exceed, assessed by incidence of device-related AEs / SAEs
Surgeon satisfaction with the device
Awards & Highlights
No Placebo Group
All patients enrolled in this trial will receive the new treatment.
2 Treatment Groups
1 of 2
1 of 2
100 Total Participants · 2 Treatment Groups
Primary Treatment: LiquiBand Exceed · No Placebo Group · N/A
DeviceExperimental Group · 1 Intervention: LiquiBand Rapid · Intervention Types: Device
DeviceExperimental Group · 1 Intervention: LiquiBand Exceed · Intervention Types: Device
Screening: ~3 weeks
Reporting: 14-days post-surgery
Who is running the clinical trial?
Advanced Medical Solutions Ltd.Lead Sponsor
9 Previous Clinical Trials
1,321 Total Patients Enrolled
1 Trials studying Surgical Wound
66 Patients Enrolled for Surgical Wound
BioStat International, Inc.Industry Sponsor
1 Previous Clinical Trials
101 Total Patients Enrolled
Alfredo Carbonnell, MDPrincipal InvestigatorPrisma Health-Upstate
Age 18+ · All Participants · 1 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
You are scheduled to have surgery on your abdomen.
Frequently Asked Questions
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any vacancies available to patients for the clinical trial?
"Confirming the details of clinicaltrials.gov, this medical study is not presently accepting participants. Initially shared on September 1st 2022 and most recently updated August 4th 2022, no new patients are being recruited for now even though 85 other trials require them urgently." - Anonymous Online Contributor